[{"orgOrder":0,"company":"Tr1X Bio","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Cell and Gene therapy","year":"2024","type":"Inapplicable","leadProduct":"TRX103","moa":"Treg cell","graph1":"Oncology","graph2":"Phase I","graph3":"Tr1X Bio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Tr1X Bio \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"Tr1X Bio \/ Inapplicable"}]
Find Oncology Clinical Drug Pipeline Developments & Deals by Tr1X Bio
Reset All
